Home › Funds › ESSEX INVESTMENT MANAGEMENT CO LLC › NVCR

ESSEX INVESTMENT MANAGEMENT CO LLC position in NVCR

NOVOCURE LTD · Health Care

ESSEX INVESTMENT MANAGEMENT CO LLC reported holding 424,133 shares of NVCR (NOVOCURE LTD) in its Q3 2026 13F filing — a position valued at US$6.8M, representing 1.01% of its reported portfolio and ranking #22 among its reported holdings. ESSEX INVESTMENT MANAGEMENT CO LLC has disclosed NVCR holdings in 7 of the last 10 reported quarters, going back to Q2 2024.

Latest position (Q3 2026)424.13K sh
Reported value held$6.76M
Portfolio Weight1.01%
First reportedQ2 2024
Last changeReduce
Updated2026-10-21

Last updated: 2026-10-21 · Source: SEC EDGAR Form 13F-HR

How ESSEX INVESTMENT MANAGEMENT CO LLC's NVCR position evolved

ESSEX INVESTMENT MANAGEMENT CO LLC first disclosed a stake in NVCR in Q2 2024 at 161,486 shares (US$2.8M). The position peaked in Q3 2026 at 424,133 shares, worth US$6.8M. Across 7 filings, ESSEX INVESTMENT MANAGEMENT CO LLC increased the stake 0 time(s), trimmed it 4 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 424,133 shares valued at US$6.8M — a reduction of -15,515 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q2 2024 161.49K $2.77M New
Q3 2024 161.94K $2.53M Hold
Q4 2024 121.83K $3.63M Reduce
Q1 2025 121.04K $2.16M Reduce
Q1 2026 452.37K $4.93M New
Q2 2026 439.65K $6.66M Reduce
Q3 2026 424.13K $6.76M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About NVCR and 13F data

NVCR (NOVOCURE LTD) is a Health Care company. 32 other funds we track also report a position in NVCR — the largest reported positions include Soleus Capital Management, L.P. (US$150.2M), Palo Alto Investors LP (US$19.4M), C WorldWide Group Holding A/S (US$14.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding NVCR

All NVCR fund holders →

FAQ

How long has ESSEX INVESTMENT MANAGEMENT CO LLC held NVCR?

ESSEX INVESTMENT MANAGEMENT CO LLC has disclosed NVCR holdings in 7 of the last 10 reported quarters, going back to Q2 2024.

What is ESSEX INVESTMENT MANAGEMENT CO LLC's current position in NVCR?

As of Q3 2026, ESSEX INVESTMENT MANAGEMENT CO LLC holds 424.13K shares of NVCR (NOVOCURE LTD), valued at $6.76M, representing 1.01% of its reported portfolio and ranking #22.

Has ESSEX INVESTMENT MANAGEMENT CO LLC been buying or selling NVCR?

In the latest 13F filing (Q3 2026), ESSEX INVESTMENT MANAGEMENT CO LLC reduced its position in NVCR. The position peaked in Q3 2026 at 424.13K shares.

Which other funds hold NVCR?

Other major institutional holders of NVCR include Soleus Capital Management, L.P., Palo Alto Investors LP, C WorldWide Group Holding A/S, among 32 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.